John Nicholson Insider Trading $NKTR NEKTAR THERAPEUTICS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Nicholson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Nicholson. John Nicholson is SVP & Chief Financial Officer in NEKTAR THERAPEUTICS ($NKTR) and SVP & Chief Operating Officer in NEKTAR THERAPEUTICS ($NKTR).
John Nicholson in NEKTAR THERAPEUTICS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Nicholson: SVP & Chief Operating Officer, SVP & Chief Financial Officer
Holdings: 162,759 shares
Current Value: $2,143,536
Latest Transaction: Aug 19 2019
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Nicholson in NEKTAR THERAPEUTICS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 18.15 | 3,819 | 69,315 | 162,759 | 166.6 K to 162.8 K (-2.29 %) |
| May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 31.37 | 4,077 | 127,895 | 166,578 | 170.7 K to 166.6 K (-2.39 %) |
| Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 42.39 | 3,822 | 162,015 | 170,655 | 174.5 K to 170.7 K (-2.19 %) |
| Jan 30 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 10.69 | 63,000 | 673,470 | 0 | |
| Jan 30 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 42.82 | 63,000 | 2,697,660 | 174,477 | 237.5 K to 174.5 K (-26.53 %) |
| Jan 30 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 10.69 | 63,000 | 673,470 | 237,477 | 174.5 K to 237.5 K (+36.11 %) |
| Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 38.25 | 5,982 | 228,812 | 174,477 | 180.5 K to 174.5 K (-3.31 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 56.90 | 65,000 | 3,698,500 | 65,000 | |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 56.90 | 65,000 | 3,698,500 | 65,000 | |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | D | 58.40 | 8,137 | 475,201 | 180,459 | 188.6 K to 180.5 K (-4.31 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | D | 58.40 | 8,137 | 475,201 | 180,459 | 188.6 K to 180.5 K (-4.31 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 26,000 | 0 | 188,596 | 162.6 K to 188.6 K (+15.99 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 26,000 | 0 | 188,596 | 162.6 K to 188.6 K (+15.99 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 83.39 | 4,917 | 410,029 | 162,596 | 167.5 K to 162.6 K (-2.94 %) |
| Mar 08 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 100.45 | 100,144 | 10,059,465 | 167,513 | 267.7 K to 167.5 K (-37.42 %) |
| Mar 08 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 98.29 | 120,000 | 11,794,800 | 267,657 | 387.7 K to 267.7 K (-30.96 %) |
| Feb 20 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 82.94 | 4,879 | 404,664 | 387,657 | 392.5 K to 387.7 K (-1.24 %) |
| Feb 02 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 11.34 | 120,000 | 1,360,800 | 0 | |
| Feb 02 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 11.34 | 120,000 | 1,360,800 | 392,536 | 272.5 K to 392.5 K (+44.03 %) |
| Dec 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 56.90 | 65,000 | 3,698,500 | 65,000 | |
| Dec 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 26,000 | 0 | 272,536 | 246.5 K to 272.5 K (+10.55 %) |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 14.41 | 50,000 | 720,500 | 50,000 | |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | D | 44.23 | 6,620 | 292,803 | 246,536 | 253.2 K to 246.5 K (-2.61 %) |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 20,000 | 0 | 253,156 | 233.2 K to 253.2 K (+8.58 %) |
| Nov 15 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 9.24 | 25,000 | 231,000 | 0 | |
| Nov 15 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 37.78 | 15,910 | 601,080 | 233,156 | 249.1 K to 233.2 K (-6.39 %) |
| Nov 15 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 9.24 | 25,000 | 231,000 | 249,066 | 224.1 K to 249.1 K (+11.16 %) |
| Aug 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 19.32 | 3,177 | 61,380 | 224,066 | 227.2 K to 224.1 K (-1.40 %) |
| Jun 09 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 6.34 | 150,000 | 951,000 | 0 | |
| Jun 09 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 19.24 | 101,700 | 1,956,708 | 227,243 | 328.9 K to 227.2 K (-30.92 %) |
| Jun 09 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 6.34 | 150,000 | 951,000 | 328,943 | 178.9 K to 328.9 K (+83.83 %) |
| May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 19.55 | 3,146 | 61,504 | 178,943 | 182.1 K to 178.9 K (-1.73 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 13.14 | 3,237 | 42,534 | 182,089 | 185.3 K to 182.1 K (-1.75 %) |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 45,000 | 209,250 | 0 | |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 45,000 | 209,250 | 185,326 | 140.3 K to 185.3 K (+32.07 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 8,505 | 39,548 | 45,000 | |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 66,495 | 309,202 | 53,505 | |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 12.48 | 8,505 | 106,142 | 140,326 | 148.8 K to 140.3 K (-5.71 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 8,505 | 39,548 | 148,831 | 140.3 K to 148.8 K (+6.06 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 12.38 | 66,495 | 823,208 | 140,326 | 206.8 K to 140.3 K (-32.15 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 66,495 | 309,202 | 206,821 | 140.3 K to 206.8 K (+47.39 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 20,000 | 0 | 140,326 | 120.3 K to 140.3 K (+16.62 %) |
| Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 13.96 | 1,654 | 23,090 | 120,326 | 122 K to 120.3 K (-1.36 %) |
| Aug 17 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 17.56 | 3,317 | 58,247 | 121,980 | 125.3 K to 122 K (-2.65 %) |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 15.55 | 22,000 | 342,100 | 22,000 | |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 26,000 | 0 | 103,630 | 77.6 K to 103.6 K (+33.49 %) |
| Jun 03 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 15.53 | 100,000 | 1,553,000 | 100,000 | |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 2,167 | 0 | 21,667 | |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 13.58 | 856 | 11,624 | 77,630 | 78.5 K to 77.6 K (-1.09 %) |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 0.00 | 2,167 | 0 | 78,486 | 76.3 K to 78.5 K (+2.84 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 2,166 | 0 | 23,834 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 11.92 | 963 | 11,479 | 76,319 | 77.3 K to 76.3 K (-1.25 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 0.00 | 2,166 | 0 | 77,282 | 75.1 K to 77.3 K (+2.88 %) |
| Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 15.55 | 26,000 | 404,300 | 26,000 | |
| Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 0.00 | 22,000 | 0 | 22,000 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 6.46 | 85,000 | 549,100 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 6.98 | 5,000 | 34,900 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 8.87 | 45,092 | 399,966 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 6.98 | 95,000 | 663,100 | 5,000 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 8.87 | 154,908 | 1,374,034 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.47 | 66,000 | 691,020 | 75,116 | 141.1 K to 75.1 K (-46.77 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 6.46 | 85,000 | 549,100 | 141,116 | 56.1 K to 141.1 K (+151.47 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.64 | 3,976 | 42,305 | 56,116 | 60.1 K to 56.1 K (-6.62 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 6.98 | 5,000 | 34,900 | 60,092 | 55.1 K to 60.1 K (+9.08 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 8.87 | 45,092 | 399,966 | 55,092 | 10 K to 55.1 K (+450.92 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.67 | 95,000 | 1,013,650 | 10,000 | 105 K to 10 K (-90.48 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 6.98 | 95,000 | 663,100 | 105,000 | 10 K to 105 K (+950.00 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.99 | 154,908 | 1,702,439 | 10,000 | 164.9 K to 10 K (-93.94 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 8.87 | 154,908 | 1,374,034 | 164,908 | 10 K to 164.9 K (+1,549.08 %) |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 10.69 | 63,000 | 673,470 | 63,000 | |
| Feb 03 2010 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 11.34 | 120,000 | 1,360,800 | 120,000 | |
| Nov 20 2009 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 9.24 | 25,000 | 231,000 | 25,000 | |
| Jun 12 2009 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 6.34 | 150,000 | 951,000 | 150,000 | |
| Mar 16 2009 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 2,500 | 0 | 7,500 | |
| Mar 16 2009 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 0.00 | 2,500 | 0 | 5,444 | 2.9 K to 5.4 K (+84.92 %) |
| Feb 25 2009 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 4.65 | 120,000 | 558,000 | 120,000 | |
| Feb 25 2009 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 4.65 | 120,000 | 558,000 | 120,000 | |
| Feb 27 2008 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 6.46 | 85,000 | 549,100 | 85,000 | |
| Dec 26 2007 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 6.98 | 100,000 | 698,000 | 100,000 | |
| Dec 12 2007 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 0.01 | 10,000 | 100 | 10,000 |
Page: 1